Copy

February 9, 2021

View in Browser
3b8fc08a-34da-4f7c-a42d-60d19953c835.png
Q4 2020

Pulse On Progress Newsletter

 
Table of Contents
 

Introduction

Transcelerate aspires for a future state where research and development is faster, more efficient and harnesses all the available information. We invision this happening three ways:

  1. Full participation across all stakeholders—clinical trial sponsors, sites, investigators, patients and their healthcare providers
  2. Information is fully used to improve the overall quality, design and development process. We protect patients through shared, proactive safety science
  3. Improving the execution of research and development through greater harmonization with the potential to conduct collaborative trials
 
 
 
 

Newest Resources & Company Milestones

 
442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
 
 
 

Pulse On Progress Updates

 
c03715de-4a7c-44af-a597-f6b8b5a6c86b.png
Patient & Site Experience

Objective: Improve the patient and site experience by decreasing burden, enabling a better-informed patient and improving clinical research awareness, participation & engagement.

442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
 
1b8c3c16-1be0-49e1-988f-fb73920fbc9e.png
Enhance Sponsor Efficiencies

Objective: Facilitate the advancement of innovative healthcare and clinical research through improved technologies, advanced data collection systems and simplified processes.

442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
  
e7af3565-82bf-4e1e-bcdb-5af4f5a6a526.png
Information Sharing & Harmonization

Objective: Enable the industry to move toward greater harmonization of process and facilitate the sharing of information amongst industry stakeholders to enable the industry to capture, optimize and experience efficiencies.

442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
 
2e495868-53fe-47cf-8ce6-34b52fb7b8d6.png
Enhance Drug Safety

Objective: Facilitate solutions that address a common set of challenges in drug safety surveillance such as engaging the public, collaborating with regulators, incorporating data and analytics, developing model approaches, and assessing the impact of efforts.

442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
 
 
 

Spotlight & The Latest

 
The Latest
   
 
CCR_No-PopUps.jpg

THE IMPORTANCE OF HARMONIZING CLINICAL TRIAL CONTENT, ESPECIALLY IN A POST-PANDEMIC WORLD

We spoke with Missy Heidelberg, senior product development industry collaborations and bioethics leader at Roche and former TransCelerate Clinical Content & Reuse website steward, about recent updates to TransCelerate’s Clinical Content & Reuse Initiative and the importance of harmonizing clinical trial content—especially in a post-pandemic world.

 
   
 
442a2f03-ecb5-4c14-8a18-34afe976cf8b.png
 
Spotlight
   
 
pexels-pixabay-373543-scaled.jpg

THE HISTORICAL TRIAL DATA SHARING INITIATIVE

We interviewed several individuals who have been instrumental in advancing the goals of the HTD Initiative including Jules Desmond, Strategic Development Organization Head, Global Clinical Development at Amgen; Liz Roberts, Data Policy and Privacy Lead at UCB; and Aaron Mann, Global Program Lead, Industry Collaborations Data Sharing Initiatives at Genentech, about data sharing progress, challenges and the future.

 
   
   
  442a2f03-ecb5-4c14-8a18-34afe976cf8b.png  
   
 
 
 

Mark Your Calendars

TransCelerate leaders and Member Companies are invited to participate and present at many biopharmaceutical research industry conferences and meetings across the globe to provide a perspective on industry challenges and clinical trial issues. Take a peek at a few places we will be presenting early next year. For detailed information on speaker presentations, visit the events page on the TransCelerate website.

 
04614e83-95f8-42f8-8ee1-f089571ba418.jpg
March 2-4, 2021

SCOPE US

Virtual Attendance

 
5c98cbc2-c1d5-4c4d-b122-97c6f14b8e68.jpg
March 12-25, 2021

Society of Toxicology Annual Meeting

Virtual Attendance

 
98bd9264-7903-4a7b-a94e-431f65c66f47.jpg
March 15-19, 2021

DIA Europe

Virtual Attendance







This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
TransCelerate BioPharma Inc. · 1001 Conshohocken State Road · STE 1-655 · Conshohocken, PA 19428 · USA